Results 321 to 330 of about 236,761 (380)

Neonatal metabolic alkalosis and mild diuresis resulting from torasemide self-medication by the mother: a case report. [PDF]

open access: yesJ Pharm Health Care Sci
Kitahiro Y   +9 more
europepmc   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto   +19 more
wiley   +1 more source

Home intravenous diuretic administration for heart failure management: A scoping review. [PDF]

open access: yesPLoS One
Krauter MB   +4 more
europepmc   +1 more source

Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF. [PDF]

open access: yesJACC Adv
Kwaah PA   +6 more
europepmc   +1 more source

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Background Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in‐hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear.
Yanxiang Sun   +6 more
wiley   +1 more source

Real‐world use of guideline‐directed therapy for heart failure: Insights from the Danish Heart Failure Registry

open access: yesESC Heart Failure, EarlyView.
Our study examined the real‐world implementation of guideline‐directed medical therapy (GDMT) and its association with mortality and hospitalization in 46 816 patients with heart failure with reduced ejection fraction (HFrEF) from the Danish Heart Failure Registry (2008–2022).
Inge Schjødt   +5 more
wiley   +1 more source

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

open access: yesESC Heart Failure, EarlyView.
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy